News Focus
News Focus
Post# of 257262
Next 10
Followers 1
Posts 1114
Boards Moderated 0
Alias Born 04/07/2009

Re: biomaven0 post# 139046

Friday, 03/23/2012 8:31:10 AM

Friday, March 23, 2012 8:31:10 AM

Post# of 257262
XNPT - The PHN indication is based on a single PII trial. That appears to satisfy the 505b2 pathway to some respect. The only question I have is about the dosage. The recommended dosage for Horizant is 600 mg daily. The PHN approval is for 600mg BID. Will this be an issue especially with the cancer issue they had earlier.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today